Godavari Biorefineries Ltd., one of the larger producers of ethanol and a pioneer in manufacturing ethanol-based chemicals in India, announced its Unaudited Financial Results for the quarter ended on December 31, 2024.
The company reported a 12% year-on-year revenue growth in Q3 FY25, reflecting resilience and strong business performance in an evolving market. Revenue from operations rose to ₹447.3 crore, up from ₹398.0 crore in Q3 FY24, with an EBITDA of ₹39.7 crore and a Profit After Tax (PAT) of ₹5.8 crore.
GBL continues to diversify revenue streams with a focus on bio-based chemicals and strengthening its ethanol division. Strategic initiatives include:
- Capacity expansion of 1,3 Butylene Glycol
- Technology licensing for Bio-Butanol and higher alcohols
- Investment in a new corn/grain-based distillery
- Debt reduction using IPO proceeds to optimize financial efficiency
Commenting on the Results, Samir Somaiya, CMD said, “We are continuing to diversify our revenue streams, with a strategic focus on bio-based chemicals and strengthening our Ethanol division through the exploration of multiple feedstocks. The Bio-chemicals and Ethanol segment is poised to become a key driver of our future expansion, reinforcing our vision of building a sustainable, innovation-led bio-refining business. In the pursuit of these goals, we have expanded capacity of 1,3 Butylene Glycol, licensed a technology to make Bio-Butanol and higher alcohols, placed an order for a corn/grain-based distillery, and used our IPO proceeds to reduce term debt which will reduce our finance costs going forward. In January 2025, the Government has allowed a million-ton export of sugar from India. This has improved sugar prices and will help the industry that was facing pricing pressures in the last quarter. With this, we are well on the path of driving efficiencies, optimizing costs, and ensuring long-term sustainable growth.”
